학술논문
Neuroblastoma suppressor of tumorigenicity 1 is a circulating protein associated with progression to end-stage kidney disease in diabetes
Document Type
Article
Author
Kobayashi, H.; Satake, E.; Md Dom, Z.I.; O’Neil, K.; Ihara, K.; Krolewski, B.; Niewczas, M.A.; Doria, A.; Krolewski, A.S.; Looker, H.C.; Saulnier, P.J.; Nelson, R.G.; D’Addio, F.; Petrazzuolo, A.; Fiorina, P.; Wilson, J.M.; Badger, H.S.; Duffin, K.L.; Corradi, D.; Galecki, A.; Wilson, P.C.; Najafian, B.; Mauer, M.; Humphreys, B.D.
Source
In: Science Translational Medicine . (Science Translational Medicine, 10 August 2022, 14(657))
Subject
Language
English
ISSN
19466242
19466234
19466234